Hidradenitis Suppurativa: Diving Deeper Into Disease Pathogenesis, Severity Assessment, and Holistic Management Approaches

Release Date: September 30, 2025

Expiration Date: September 30, 2026

Activity Overview

Hidradenitis suppurativa (HS) is a chronic, inflammatory skin disease that significantly impacts patients’ quality of life, yet it remains underrecognized and often misdiagnosed. Characterized by recurrent and painful nodules, abscesses, and scarring, HS poses diagnostic and therapeutic challenges. With growing research into the pathophysiology and emerging treatment options for this condition, there is a pressing need for clinicians to stay informed on best practices in the management of HS.

In this continuing education activity, faculty experts will review disease pathogenesis, highlight the role of inflammation and microbial dysbiosis, and provide updates on evolving treatment strategies, including medical, surgical, and multidisciplinary approaches. Practical guidance will be shared regarding the assessment of disease severity and strategies to improve long-term outcomes.

Target Audience

This educational activity is directed toward dermatologists, dermatology PAs, NPs, RNs, and other HCPs involved in the management of HS.

Learning Objectives

Upon successful completion of this activity, you should be better prepared to:

• Explain the key events and mechanisms involved in the pathogenesis of hidradenitis suppurativa
• Assess disease severity using recommended instruments and evaluations in clinical practice
• Identify disease phenotypes in diverse patient populations with hidradenitis suppurativa
• Implement evidence-based, holistic treatment strategies in the management of hidradenitis suppurativa

Faculty, Staff, and Planners’ Disclosures

The staff of Physicians’ Education Resource^®, LLC have no relevant financial relationships with ineligible companies.

PER^® mitigated all COI for faculty, staff, and planners prior to the start of this activity by using a multistep process.

Off-Label Disclosure and Disclaimer

This activity may or may not discuss investigational, unapproved, or off-label use of drugs. Learners are advised to consult prescribing information for any products discussed. The information provided in this accredited activity is for continuing education purposes only and is not meant to substitute for the independent clinical judgment of a health care professional relative to diagnostic, treatment, or management options for a specific patient’s medical condition. The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER^® or any company that provided commercial support for this activity.